Follow
Sadisna Shahi
Sadisna Shahi
Texas Tech University Health Sciences Center
Verified email at ttuhsc.edu
Title
Cited by
Cited by
Year
Design, synthesis and structure-activity relationship study of novel urea compounds as FGFR1 inhibitors to treat metastatic triple-negative breast cancer
M Ashraf-Uz-Zaman, S Shahi, R Akwii, MS Sajib, MJ Farshbaf, RR Kallem, ...
European journal of medicinal chemistry 209, 112866, 2021
92021
Evaluation of Urea-Based Inhibitors of the Dopamine Transporter Using the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis
M Ashraf-Uz-Zaman, G Ji, D Tidwell, L Yin, S Thakolwiboon, J Pan, ...
ACS chemical neuroscience 13 (2), 217-228, 2022
32022
Mechanistic Aspects of Biphenyl Urea-Based Analogues in Triple-Negative Breast Cancer Cell Lines
R Bandy, S Shahi, N Quagraine, S Shahbazi Nia, MSI Howlader, ...
ACS Pharmacology & Translational Science 7 (1), 120-136, 2023
12023
Characterization of a Nonselective Opioid Receptor Functional Antagonist: Implications for Development as a Novel Opioid Dependence Medication.
YT Ortiz, ZG JD, L Shamir, K Frimpong-Manson, MA Hossain, S Shahi, ...
ACS Pharmacology & Translational Science 7 (3), 654-666, 2024
2024
Characterization of a Nonselective Opioid Receptor Functional Antagonist: Implications for Development as a Novel Opioid Dependence Medication
S Shahbazi Nia, YT Ortiz, JD Zuarth Gonzalez, L Shamir, ...
ACS Pharmacology & Translational Science, 2024
2024
Correction to “Evaluation of Urea-Based Inhibitors of the Dopamine Transporter Using the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis”
M Ashraf-Uz-Zaman, G Ji, D Tidwell, L Yin, S Thakolwiboon, J Pan, ...
ACS Chemical Neuroscience 13 (21), 3138-3138, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–6